Friday ID Conference: “Humoral Immunity Benchmarks for Advancing HIV-1 Vaccine Candidates”

Georgia TomarasThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“Humoral Immunity Benchmarks for Advancing HIV-1 Vaccine Candidates”
Georgia Tomaras, Ph.D.
Duke Human Vaccine Institute

November 14, 2014
8:30 – 9:30 a.m.
1131 Bioinformatics
UNC Campus

Dr. Georgia Tomaras is a tenured Associate Professor of Surgery, Immunology, and Molecular Genetics and Microbiology at Duke University Medical Center. She is the P.I. of the Laboratory of Immune Responses and Virology, Director of the DHVI Training Program, and Associate Director of Research for the Duke Human Vaccine Institute. She is Associate Director for the HIV Vaccine Trial Network Laboratory Center (Duke PI) and Director of the Duke CFAR Immunology Core. Research in the Tomaras lab focuses on understanding the ontogeny and anti-HIV activity of cellular and humoral immune responses as well as the identification of HIV-1 humoral immune correlates.

Special Note: This Friday Morning Conference event will be presented as an NCATEC training, and advanced registration is requested. Register here.

Friday ID conference: “Organized Crime, Kevin Bacon & Air Traffic: Lessons for HIV Prevention”

susanThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“Organized Crime, Kevin Bacon & Air Traffic: Lessons for HIV Prevention”

Susan Little, MD
University of California, San Diego (UCSD)

November 7, 2014
8:30 – 9:30 a.m.
1131 Bioinformatics
UNC Campus

Susan Little, M.D. is a Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). She conducts translational clinical research focused on the pathogenesis, prevention and treatment of acute and very recent HIV infection. She is the director of the Primary Infection Research Program at UCSD, working to evaluate the epidemiologic, behavioral, biologic, virologic, and host factors that contribute to HIV transmission. She has been heavily involved in the design of novel approaches to screen and identify acutely infected individuals, and use of molecular epidemiologic methods to infer and characterize HIV transmission networks. Current research is focused on the evaluation of treatment and prevention interventions directed to network hubs to reduce incident infections. She is actively involved in the training and mentoring of students, post-doctoral research fellows and junior faculty and is an active investigator in the UCSD AIDS Clinical Trials Group.

Special Note: This Friday Morning Conference event will be presented as an NCATEC training, and advanced registration is requested. For questions about registration or general questions about the NCATEC, please contact

Register here

HIV & Aging: From Mitochondria to the Metropolis

HIV Aging MentoringRegistration is open for the “HIV & Aging: From Mitochondria to the Metropolis” Conference

October 2&3, 2014, Marriott Courtyard Decatur; Decatur, GA

A translational science meeting to address the basic science, clinical and socio-behavioral aspects of Aging with HIV/AIDS.

Preceding the conference will be a Mentoring Workshop for junior faculty qualifying as early stage and new investigators and post-doctoral fellows who have already identified a research topic at the intersection of HIV and Aging about which they have a research idea.

For conference agenda and more information, visit:

Friday ID Conference: Acceptability of Male Circumcision for HIV Prevention in the Dominican Republic

BritoThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“The Acceptability of Male Circumcision for HIV Prevention in the Dominican Republic”
Max Brito, MD, MPH
University of Illinois at Chicago

September 26, 2014
8:30 – 9:30 a.m.
1131 Bioinformatics
UNC Campus (directions)

Max Brito, MD, MPH is an Associate Professor and Vice Chair for Urban Global Health in the Department of Medicine at the University of Illinois at Chicago. His clinical research focuses on HIV prevention in the Caribbean. He specializes in the treatment of patients co-infected with the HIV and hepatitis viruses.

Dr. Brito’s main areas of interest are International health, HIV co-infections and medical education. He serves as the coordinator of the Dominican Republic Project, an educational exchange program with the aim of promoting scientific collaborations with colleagues in that country and in the rest of Latin America. He also has a clinical interest in the care of patients co-infected with the HIV and HCV/HBV viruses and the impact of that epidemic in the US Hispanic population. He is also interested in medical education, particularly in studying effective methods to teach US medical trainees in international settings. Dr. Brito is currently the Program Director for the University of Illinois ID fellowship program; he trained in Internal Medicine at Mount Sinai Medical Center and completed an Infectious Diseases fellowship at the University of Miami, School of Medicine.

Refreshments will be served.

HIV/AIDS Stigma Talk with James Kiwanuka-Tondo

Kiwanuka-TondoJames Kiwanuka-Tondo, associate professor in the NC State Department of Communication, will give a talk on about HIV/AIDS stigma as part of the Mary Junck Research Colloquium Series

HIV/AIDS Stigma: Discussions from Black Female College Students on the role of religious organizations and health institutions in promoting dialogue and dissipating shame

September 19, 2014 from 3-4 p.m.
Freedom Forum Conference Center
3rd Floor Carroll Hall, UNC-CH Campus

While a lot of research has been done on traditionally thought of high-risk demographics, such as drug users and sex workers, little is known about HIV/AIDS-related stigma and its impact on the black female college population. HIV/AIDS-related stigma is prevalent in society and may prevent individuals from engaging in health information seeking regarding prevention, testing, and care. Our findings indicate that study participants perceived family, religious organizations and health care institutions as significantly impacting the promotion or dissipation of HIV/AIDS stigma. Awareness and understanding of students’ opinions and perceptions about stigma can assist health care personnel and religious leaders in developing prevention programs and services for individuals and their families within this particular group.

Dr. James Kiwanuka-Tondo is an Associate Professor and Coordinator of the Public Relations curriculum in the Department of Communication at North Carolina State University. He is currently a Park Faculty Scholar for the Park Scholars Class of 2016. His main area of research is health communication campaigns with particular emphasis on HIV/AIDS. His major contribution has been the development of the first ever quantitative model of relationships between organizational factors, campaign planning, and campaign execution variables. His work on HIV/AIDS has been published in a number of journals. He has been a principal investigator on several research grants and is currently Co-PI on a research project funded by a larger grant from the National Science Foundation with a purpose of developing culturally sensitive HIV/AIDS prevention messages for Black College Female students.

Friday ID Conference: Progress and Challenges in STI Research

King HolmesThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“Progress and Challenges in STI Research”
King Holmes, MD, PhD, FIDSA
Department of Global Health at University of Washington

September 19, 2014
8:30 – 9:30 a.m.
4th Floor Old Clinic, UNC-CH Campus

King K. Holmes MD, PhD, FIDSA, has dedicated 50 years to research on the epidemiology, diagnosis, and treatment and prevention of sexually transmitted infections. From 2006-2014, Dr. Holmes served as the first William H. Foege Chair of the Department of Global Health at the University of Washington, where he is Professor of Global Health and Medicine, and Adjunct Professor of Microbiology and Epidemiology. He also heads the Infectious Diseases Section at Harborview Medical Center. He founded and directs the UW Center for AIDS and STD, a WHO Collaborating Center.

Refreshments will be served.

Dr. Joseph Tucker works globally to educate HIV researchers

clinical skills training

Professor Beng Tin Goh teaches STD clinical skills at the 2014 UNC-South China STD Research Training course

The UNC CFAR has a robust membership of doctors and researchers who work internationally to increase knowledge, decrease stigma, and provide care and support in the field of HIV/AIDS. CFAR investigator Dr. Joseph Tucker, assistant professor at the UNC School of Medicine and director of UNC Project-China, is doing innovative work in developing social and biomedical research, and capable global scientists, to work on controlling the spread of HIV/AIDS.

Dr. Tucker’s research examines how major shifts in China’s social and economic climate have resulted in the resurgence of syphilis, HIV, and other STIs. He has ongoing projects that focus on social entrepreneurship for sexual health and the social epidemiology of STIs. He lives and works throughout the year with his family in Guangzhou, the capitol of Guangdong Province, and is fluent in Mandarin Chinese. He is PI on an NIH Fogarty International Research Scientist Development Award and serves as a mentor for trainees and junior investigators.

This past summer, Dr. Tucker facilitated the UNC-South China STD Research Training course – an intensive, week-long training course that Tucker described as “fantastic because it provides a structured mechanism to support junior Chinese trainees interested in STD/HIV research”. The training course included academic lectures on clinical science, epidemiology, and diseases prevention, as well as skills building workshops on grant writing, data collection, and project management. Tucker shared, “Despite the sweltering heat (one UNC professor said it felt just like home) and a packed agenda, there was great enthusiasm from both the China and UNC participants. We had a 360 evaluation that included participant evaluation, training faculty evaluation, and external evaluation. The consensus was that the training course exceeded trainee expectations and filled an important niche, catering to junior trainees who often do not have a chance to attend international conferences or get an opportunity to receive guidance from UNC training faculty. The whole point of the training course was to jump start research collaborations between UNC training faculty and Chinese faculty and trainees. With the D43 (mentoring) grant, now we can have a far more reciprocal training experience that is beneficial for all involved.” September 10th is “Teacher’s Day” in China and the Guangzhou postdocs have organized a dinner in honor of Teacher Joe.

Faculty and Students at the 2014 UNC-South China STD Research Training course. UNC CFAR investigators Dr. Mike Cohen, Dr. Joe Eron, Dr. Heidi Swygard

Faculty and Students at the 2014 UNC-South China STD Research Training course. UNC CFAR members Drs. Joseph Tucker, Mike Cohen, Joseph Eron, Heidi Swygard, Peter Leone, Arlene Sena, P. Frederick Sparling, and Ada Adimora were in attendance.

Dr. Tucker’s work spans across the globe; his project searcHIV: Social and Ethical Aspects of Research on Curing HIV is comprised of a multi-site, multi-disciplinary working group focusing on investigating the biosocial implications of curing HIV infection. They have three research sites, located in Cape Town, South Africa, Chapel Hill, NC and Guangzhou, China. Tucker explained, “From an anthropological perspective, there are substantial differences in the social context of HIV in the US, South Africa, and China. For example, take civil society organizations. In the US, civil society organizations were leading the calls for accelerated HIV ART approval at the FDA and have played a pivotal role to push forward new HIV policies. In South Africa, there is also a strong civil society presence, but organized along different themes and strategies. In China, the development of civil society has been more complex, creating challenges in reaching and retaining key populations in some contexts.” The multiple study sites give his team opportunities for cross-cultural comparisons, which help in identifying intersecting themes about the unintended implications of HIV cure. Tucker’s research “hopes to take advantage of these cultural and social differences” as his teams analyze the social and ethical dimensions of cure HIV research.

The results of Tucker’s investigations can be used to assist HIV cure researchers as they create informed consent documents, design research studies, and continue HIV cure research. Tucker noted, “We are fortunate to have Professor David Margolis’s CARE team at UNC. They are an absolutely top-notch group, world leaders in the basic science and clinical aspects of HIV cure research. We are also excited to learn more about structuring community engagement on this topic and how to engage a broad range of stakeholders.”

Combination Therapy in HIV Cure Research Conference

Dr David MargolisThe Collaboratory of AIDS Researchers for Eradication (CARE) is hosting a community presentation:

Combination Therapy in HIV Cure Research
Monday, September 15, 2014
11 am – 12 pm EDT | 8 – 9 am PDT

Speaker: David M. Margolis, MD, FACP
Professor of Medicine, Microbiology and Immunology, Epidemiology
Principal Investigator, Collaboratory of AIDS Researchers for Eradication (CARE)
The University of North Carolina at Chapel Hill (UNC-CH)
Institute for Global Health and Infectious Diseases (IGHID)

To join the online meeting:

1. Go to this website.
2. If requested, enter your name and email address.
3. If a password is required, enter the meeting password: care2cure
4. Click “Join”.

To join the audio conference through telephone:

US TOLL FREE: +1-855-282-6330
US TOLL: +1-415-655-0003

Time: 10:45 am, Eastern Daylight Time
Meeting Number: 734-892-997
Meeting Password: care2cure

For assistance, visit this website. On the left navigation bar, click “Support”.

Friday ID Conference: Dynamics and Clinical Relevance of Drug Resistant HIV

boucherThis talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series.

“Dynamics and Clinical Relevance of Drug Resistant HIV; the end of the problem”
Speaker: Charles Boucher MD, PhD
Erasmus University Rotterdam, The Netherlands

September 12, 2014
8:30 – 9:30 a.m.
1131 Bioinformatics (first floor auditorium), UNC-CH Campus

Charles Boucher is Professor in the Department of Virology Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands. Professor Boucher received his medical degree and PhD from the Faculty of Medicine of the University of Amsterdam, The Netherlands. He then furthered his studies in clinical microbiology and virology at the Academic Medical Center, Amsterdam and the University Medical Center Utrecht. He is the chairman of the European Society for Antiviral Resistance.

Professor Boucher is an organizer of international workshops, meetings and conferences, a consultant throughout Europe and the United States, a reviewer for scientific journals and co-chairman of several international committees. He is the author of numerous publications that have appeared in such journals as Science, The Lancet, Nature Medicine, Journal of Infectious Diseases and AIDS.

Refreshments will be served.